| abstract |
The invention is directed to purified and isolated polypeptides, the nucleic acids encoding such polypeptides that have altered expression characteristic s in the T84 gut barrier model, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragment ed peptides derived from these polypeptides, and the uses to study inflammatory bowel diseas (IBD). |